School of Medicine researcher Christopher Stroupe is targeting a set of molecules that are essential for Ebola to infect cells and for cancer cells to grow and survive.

The drug, pevonedistat, acts on a protein critical to the rapid reproduction of cancer cells and may even be effective against melanomas that have resisted other forms of treatment.

The New England Journal of Medicine published the results of an international clinical trial led by UVA that has validated the use of focused ultrasound to treat essential tremor, and the procedure has been approved by the FDA.

Medical researchers may have unlocked a way to slow, or perhaps stop, the growth of small cell lung cancer, which plagues smokers in particular and makes up approximately 15 percent of all cancer cases.

A new discovery suggests a way to stop an infection the CDC has labeled an urgent threat.

UVA researchers have identified a molecule that plays an important role in battling pneumonia. It might offer a new venue for treating antibiotic-resistant pneumonia infections.

Following last year’s groundbreaking discovery of a direct link between the brain and the immune system, UVA researchers have determined that the immune system affects – and even controls – social behavior. Their discovery could profoundly affect treatment of several neurological disorders.

The procedure uses focused ultrasound waves to alleviate the suffering of essential tremor patients – without incisions or implanting any devices.

In a breakthrough called “as unexpected as it is important,” UVA researchers have found that a cell normally blamed for causing allergies and asthma provides protection against potentially deadly infections.

UVA researchers have identified compounds that may someday allow bodies to resist and repair damage from ionizing radiation.